Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

News & Analysis

China biotech company and industry news and analysis...

BioCity Completes Enrollment of ETA Agonist Trial in Patients with IgA Nephropathy

Longbio of Suzhou Says LP-003 Effective in Patients with Allergic Rhinitis

Week in Review: AlphaGen and ArtBio Form China-US Radioligand Partnership

CHMP Recommends Approval of Legend’s CAR-T as Second-Line Multiple Myeloma Therapy

Immunofoco to Start US Trial of CAR-T for Gastrointestinal Tumors

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital